Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse Syndecan-1/CD138 Antibody, R&D Systems™

Rat Monoclonal Antibody has been used in 2 publications
Supplier: R&D Systems MAB2966SP
This item is not returnable.
View return policy
Description
Syndecan-1/CD138 Monoclonal specifically detects Syndecan-1/CD138 in Mouse samples. It is validated for Flow Cytometry, Immunocytochemistry, CyTOF-ready.Specifications
Syndecan-1/CD138 | |
Monoclonal | |
LYOPH | |
Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready | |
P18828 | |
SDC1 | |
Mouse myeloma cell line NS0-derived recombinant mouse Syndecan-1/CD138 isoform 1 Gln18-Glu252 Accession # P18828 | |
25 μg | |
Primary | |
Detects mouse Syndecan-1/CD138 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human Syndecan-1, recombinant mouse (rm) Syndecan-3 or rmSyndecan-4 is observed. | |
Mouse | |
Purified |
Flow Cytometry, Immunocytochemistry, CyTOF | |
300506 | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
CD138, CD138 antigen, SDC, SDC1, SYND1heparan sulfate proteoglycan fibroblast growth factor receptor, syndecan, syndecan 1, syndecan proteoglycan 1, syndecan-1, Syndecan1 | |
Rat | |
Protein A or G purified from hybridoma culture supernatant | |
RUO | |
6382 | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
IgG1 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction